Menu
Enrolling by invitation NCT06842212

Balance Training To Enhance Stability And Athletic Performance During The Menstrual Cycle

No phase Interventional Menstrual Cycle Phase Athletic Performance Balance Training

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Balance Training.
Who it may be relevant to
Registry conditions: Menstrual Cycle Phase, Athletic Performance, Balance Training. Basic parameters: 18 years — 22 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Targeted Balance Training During The Menstrual Cycle To Enhance Stability And Athletic Performance: A Randomized Controlled Trial

Overview

This study was done to investigate the effect of balance training on improving balance and athletic performance during menstrual cycle in young athletic females Does balance training improve balance and athletic performance during the menstrual cycle? 60 athletic females will participate in the study. They will be randomly assigned into two groups. Group A will receive balance training on biodex, while group B will be the control group.

Interventions

  • Device Balance Training
    balance training exercises performed on the biodex balance system 3 sessions every week for 12 weeks

Primary outcome measures

  • Balance [Time frame: 12 weeks]
Secondary outcome measures (2)
  • atheletic performance [Time frame: 12 weeks]
  • Athletic dynamic balance [Time frame: 12 weeks]

Eligibility criteria

Inclusion criteria

  • Their age will be ranged from 18 to 22. Their BMI will be from 18.5 to 25 kg/cm2 - Athletes

Exclusion criteria

  • free of musculoskeletal or neurological diseases that could affect balance/ taking any medications that affect sex hormones

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • British University in Egypt — Cairo

Identifiers

NCT: NCT06842212 · P.T.REC/012/005603

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗